Use of a Removable Backbone Modification Strategy to Prevent Aspartimide Formation in the Synthesis of Asp Lactam Cyclic Peptides †
Tingting Cui,Junyou Chen,Rui Zhao,Yanyan Guo,Jiahui Tang,Yulei Li,Yi‐Ming Li,Donald Bierer,Lei Liu
DOI: https://doi.org/10.1002/cjoc.202100272
IF: 5.56
2021-07-26
Chinese Journal of Chemistry
Abstract:<p>The synthesis of an Asp lactam derivative of A-183, a selective inhibitor of Factor 7a with good anticoagulant and antithrombotic activity, is described. Our synthesis depends on the use of a removable backbone modification (RBM) strategy to prevent aspartimide formation, which thwarted all attempts to synthesize this target using direct solid-phase peptide synthesis. Validation of the RBM strategy in the synthesis of a second Asp lactam derivative was also accomplished. The RBM strategy is therefore proposed as a general method for the synthesis of Asp lactam cyclic peptides.</p><p>This article is protected by copyright. All rights reserved.</p>
chemistry, multidisciplinary